Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Vanilloid receptors--do they have a role in whole body metabolism? Evidence from TRPV1.

Zsombok A.

J Diabetes Complications. 2013 May-Jun;27(3):287-92. doi: 10.1016/j.jdiacomp.2012.11.006. Epub 2013 Jan 16. Review.

2.

Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.

Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.

Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.

3.

Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis.

Wang P, Yan Z, Zhong J, Chen J, Ni Y, Li L, Ma L, Zhao Z, Liu D, Zhu Z.

Diabetes. 2012 Aug;61(8):2155-65. doi: 10.2337/db11-1503. Epub 2012 Jun 4.

4.

Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance.

Lee E, Jung DY, Kim JH, Patel PR, Hu X, Lee Y, Azuma Y, Wang HF, Tsitsilianos N, Shafiq U, Kwon JY, Lee HJ, Lee KW, Kim JK.

FASEB J. 2015 Aug;29(8):3182-92. doi: 10.1096/fj.14-268300. Epub 2015 Apr 17.

PMID:
25888600
5.

The emerging role of TRPV1 in diabetes and obesity.

Suri A, Szallasi A.

Trends Pharmacol Sci. 2008 Jan;29(1):29-36. Epub 2007 Dec 4. Review.

PMID:
18055025
6.

Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes.

Gram DX, Ahrén B, Nagy I, Olsen UB, Brand CL, Sundler F, Tabanera R, Svendsen O, Carr RD, Santha P, Wierup N, Hansen AJ.

Eur J Neurosci. 2007 Jan;25(1):213-23.

PMID:
17241282
7.

Endothelin-mediated in vivo pressor responses following TRPV1 activation.

Ohanyan VA, Guarini G, Thodeti CK, Talasila PK, Raman P, Haney RM, Meszaros JG, Damron DS, Bratz IN.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H1135-42. doi: 10.1152/ajpheart.00082.2011. Epub 2011 Jun 24.

8.

Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels.

Guarini G, Ohanyan VA, Kmetz JG, DelloStritto DJ, Thoppil RJ, Thodeti CK, Meszaros JG, Damron DS, Bratz IN.

Am J Physiol Heart Circ Physiol. 2012 Jul 15;303(2):H216-23. doi: 10.1152/ajpheart.00011.2012. Epub 2012 May 18.

9.

Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.

Zhang LL, Yan Liu D, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ, Schrader M, Thilo F, Zhu ZM, Tepel M.

Circ Res. 2007 Apr 13;100(7):1063-70. Epub 2007 Mar 8.

10.

Transient receptor potential vanilloid in blood pressure regulation.

Hollis M, Wang DH.

Curr Opin Nephrol Hypertens. 2013 Mar;22(2):170-6. doi: 10.1097/MNH.0b013e32835c8d4c. Review.

PMID:
23274405
11.
12.

TRPV1 properties in thoracic dorsal root ganglia neurons are modulated by intraperitoneal capsaicin administration in the late phase of type-1 autoimmune diabetes.

Radu BM, Iancu AD, Dumitrescu DI, Flonta ML, Radu M.

Cell Mol Neurobiol. 2013 Mar;33(2):187-96. doi: 10.1007/s10571-012-9883-6. Epub 2012 Oct 31.

PMID:
23111447
13.
14.

Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.

Sullivan TJ, Miao Z, Zhao BN, Ertl LS, Wang Y, Krasinski A, Walters MJ, Powers JP, Dairaghi DJ, Baumgart T, Seitz LC, Berahovich RD, Schall TJ, Jaen JC.

Metabolism. 2013 Nov;62(11):1623-32. doi: 10.1016/j.metabol.2013.06.008. Epub 2013 Aug 15.

PMID:
23953944
15.

'Sensing' the link between type 1 and type 2 diabetes.

Tsui H, Paltser G, Chan Y, Dorfman R, Dosch HM.

Diabetes Metab Res Rev. 2011 Nov;27(8):913-8. doi: 10.1002/dmrr.1279. Review.

PMID:
22069284
16.

Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation.

Li Q, Li L, Wang F, Chen J, Zhao Y, Wang P, Nilius B, Liu D, Zhu Z.

Pflugers Arch. 2013 Sep;465(9):1303-16. doi: 10.1007/s00424-013-1274-4. Epub 2013 Apr 21.

PMID:
23605066
17.

Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.

Mascarenhas DC, Gomes KS, Nunes-de-Souza RL.

Behav Brain Res. 2013 Aug 1;250:308-15. doi: 10.1016/j.bbr.2013.05.023. Epub 2013 May 21.

PMID:
23707246
18.

Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes.

Schnabel CA, Wintle M, Kolterman O.

Vasc Health Risk Manag. 2006;2(1):69-77. Review.

19.

Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonist.

Tanaka H, Shimaya A, Kiso T, Kuramochi T, Shimokawa T, Shibasaki M.

Life Sci. 2011 Mar 14;88(11-12):559-63. doi: 10.1016/j.lfs.2011.01.016. Epub 2011 Jan 26.

PMID:
21277869
20.

TRPV1 activation improves exercise endurance and energy metabolism through PGC-1α upregulation in mice.

Luo Z, Ma L, Zhao Z, He H, Yang D, Feng X, Ma S, Chen X, Zhu T, Cao T, Liu D, Nilius B, Huang Y, Yan Z, Zhu Z.

Cell Res. 2012 Mar;22(3):551-64. doi: 10.1038/cr.2011.205. Epub 2011 Dec 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk